BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3154445)

  • 21. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations into the lack of consensus in the reporting of HLA antibody specificities in the UK.
    Wortley A; Mckinley K; Whittle R; Calvert A; Shaw O; Fernando R; Pearse A; Hopkins K; Clark B
    J Clin Pathol; 2009 Mar; 62(3):270-4. PubMed ID: 19251955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical importance of pre-morteum blood lymphocytes in cadaver donor tissue typing.
    Vaidya S; Orchard P; Schroeder N; Haneke R; Brooks K; Thomas A; Corba A; Asfour A; Fish JC
    Clin Transplant; 1995 Jun; 9(3 Pt 1):165-70. PubMed ID: 7549055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a differential strength of specific HLA mismatches in kidney transplants?
    Sasaki N; Idica A; Terasaki P
    Transplant Proc; 2008 May; 40(4):1091-4. PubMed ID: 18555121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.
    Rodey G; Bollig B; Oldfather J; Schutte L; Flye W; Phelan D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):778-9. PubMed ID: 3274872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histocompatibility-transplant correlation, reproducibility, and new matching methods.
    Terasaki PI; Mickey MR
    Transplant Proc; 1971 Jun; 3(2):157-71. PubMed ID: 4944051
    [No Abstract]   [Full Text] [Related]  

  • 28. [Computer analysis of anti-HLA sera: ANASER. Its application in kidney transplantation].
    Busson M; Gony J; Hors J
    Pathol Biol (Paris); 1983 Dec; 31(10):833-8. PubMed ID: 6366703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for new donor typing based on donor HLA type or donor characteristics.
    Little AM; Jindra P; Raffoux C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
    Duquesnoy RJ; Claas FH
    Tissue Antigens; 2007 Apr; 69 Suppl 1():180-4. PubMed ID: 17445196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quality control program for crossmatching procedures for solid organ transplantation. The participating laboratories of the Australasian and South Asian Tissue Typing Association.
    Howden AJ; Sayer DC; Bennett G; Smith LK; Christiansen FT
    Hum Immunol; 2000 Apr; 61(4):419-24. PubMed ID: 10715519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A collaborative scheme for tissue typing and matching in renal transplantation. 3. A preliminary assessment of the influence of histocompatibility matching grades on the outcome of renal transplantation.
    Festenstein H; Oliver RT; Sachs JA
    Transplant Proc; 1971 Jun; 3(2):1011-4. PubMed ID: 4944043
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry.
    Maiers M; Hurley CK; Perlee L; Fernandez-Vina M; Baisch J; Cook D; Fraser P; Heine U; Hsu S; Leffell MS; Mauer D; Noreen H; Tang T; Trucco M; Yang SY; Hartzman RJ; Setterholm M; Winden T; Shepherd D; Hegland J
    Rev Immunogenet; 2000; 2(4):449-60. PubMed ID: 12361088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International sera exchange analyses in relation to DNA sequences: summary report from 1990 to 1994.
    Park MS; Lau M; Geer LI; Terasaki PI
    Clin Transpl; 1994; ():489-508. PubMed ID: 7547578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cooperative kidney typing and exchange program.
    Horisberger B; Jeannet M; De Weck A; Frei PC; Grob P; Thiel G
    Helv Med Acta; 1970 Oct; 35(4):239-47. PubMed ID: 4918735
    [No Abstract]   [Full Text] [Related]  

  • 37. The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
    Schreuder GM; Hurley CK; Marsh SG; Lau M; Fernandez-Vina M; Noreen HJ; Setterholm M; Maiers M; ; ; ; ;
    Tissue Antigens; 2005 Jan; 65(1):1-55. PubMed ID: 15663741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposal for an International Registry and Depository of Hyperacute Rejection after kidney transplantation.
    Doxiadis II; Claas FH
    Transplant Proc; 1996 Feb; 28(1):225. PubMed ID: 8644190
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality control for registry HLA data.
    Tiercy JM; Fischer G; Setterholm M
    Tissue Antigens; 2007 Apr; 69 Suppl 1():13-4. PubMed ID: 17445155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.